Tuesday, February 23, 1993

Session III. Pharmaceutical And Biotech Innovation

(continued)

Moderator:

Stanley Reiser, University of Texas Health Science Center

Respondents:

Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association

8:00 a.m.

Innovation in Compounds to Treat Diabetes

Introduction: Scott Stern, Stanford University

Discussion

9:00

What Is Public? What Is Private? And What Should Be?

Richard Nelson, Columbia University

Discussion

9:30

General Discussion

10:00

Break

10:30

Where Do We Go From Here?

Ken Melmon, Stanford University

Richard Nelson, Columbia University

Nathan Rosenberg, Stanford University

11:00

Adjournment



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement